Key result
Oligo- and polyribonucleotides inhibit viral proliferation through various mechanisms, including interferon induction, mRNA complementation, and reverse transcriptase inhibition.
Oligo- and polyribonucleotides show potential as antiviral agents through mechanisms such as interferon induction, mRNA complementation, and reverse transcriptase inhibition.
Answers are grounded in this paper and cite their sources.
May warrant preclinical antiviral development; leaves open clinical efficacy without prospective trials.
Current antiviral therapies are insufficient for treating emerging, re-emerging and established viral diseases. In an effort to find new therapeutics, oligo- and polyribonucleotides are being studied for their antiviral capabilities. Studies have shown that uniquely modified single- and double-stranded nucleic acid constructs are effective in inhibiting viral proliferation by various mechanisms. This review gives a brief history and highlights the development of oligo- and polyribonucleotides as antiviral agents primarily in the fields of interferon induction, mRNA complementation and reverse transcriptase inhibition.
No takes yet. Share an insight, caveat, or question.
Markosian et al. (2005) conducted a review in Viral diseases. Oligo- and polyribonucleotides was evaluated on Antiviral activity. Oligo- and polyribonucleotides inhibit viral proliferation through various mechanisms, including interferon induction, mRNA complementation, and reverse transcriptase inhibition.
Synapse has enriched 10 related papers. Consider them for comparative context: